0126Z0.KS
Samsung Epis Holdings
KOE · Healthcare · Biotechnology · KR
KRW 355,500.00
−2.34%Margins
Gross margin
5.9%
EBITDA margin
1.8%
EBIT margin
-23.5%
Net margin
33.9%
FCF margin
-43.7%
8.9%
Return on equity
6.6%
Return on assets
-5.5%
Return on invested capital
—
Asset turnover
-KRW 97.1B
Cash from operations
KRW 4.1K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026